Smallpox and Mpox Vaccine, Live, Non-replicating
| Brand name | Jynneos |
|---|---|
| Active ingredient | Smallpox and Mpox Vaccine, Live, Non-replicating |
| Strength | 0.5-3.95 X 10E8 INF. U/.5ML |
| Dosage form | For Injection |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | March 2025 |
| Marketing status | Rx |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.